tradingkey.logo
tradingkey.logo
Search

Treace Medical Concepts Inc

TMCI
Add to Watchlist
4.210USD
-0.020-0.47%
Close 07/02, 13:00ETQuotes delayed by 15 min
272.75MMarket Cap
LossP/E TTM

TradingKey Stock Score of Treace Medical Concepts Inc

Currency: USD Updated: 2026-07-02

Key Insights

Treace Medical Concepts Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 118 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 4.00.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Treace Medical Concepts Inc's Score

Industry at a Glance

Industry Ranking
118 / 204
Overall Ranking
283 / 4565
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Treace Medical Concepts Inc Highlights

StrengthsRisks
Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 212.69M.
Overvalued
The company’s latest PE is -4.40, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 37.97M shares, decreasing 29.23% quarter-over-quarter.
Held by Bill Nygren | OAKMX
Star Investor Bill Nygren | OAKMX holds 11.90K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.99.

Analyst Rating

Based on 5 analysts
Hold
Current Rating
4.000
Target Price
-5.44%
Upside Space

FAQs

How does TradingKey generate the Stock Score of Treace Medical Concepts Inc?

The TradingKey Stock Score provides a comprehensive assessment of Treace Medical Concepts Inc based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Treace Medical Concepts Inc’s performance and outlook.

How do we generate the financial health score of Treace Medical Concepts Inc?

To generate the financial health score of Treace Medical Concepts Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects Treace Medical Concepts Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Treace Medical Concepts Inc.

How do we generate the company valuation score of Treace Medical Concepts Inc?

To generate the company valuation score of Treace Medical Concepts Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Treace Medical Concepts Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Treace Medical Concepts Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Treace Medical Concepts Inc.

How do we generate the earnings forecast score of Treace Medical Concepts Inc?

To calculate the earnings forecast score of Treace Medical Concepts Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Treace Medical Concepts Inc’s future.

How do we generate the price momentum score of Treace Medical Concepts Inc?

When generating the price momentum score for Treace Medical Concepts Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of Treace Medical Concepts Inc’s prices. A higher score indicates a more stable short-term price trend for Treace Medical Concepts Inc.

How do we generate the institutional confidence score of Treace Medical Concepts Inc?

To generate the institutional confidence score of Treace Medical Concepts Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Treace Medical Concepts Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Treace Medical Concepts Inc.

How do we generate the risk management score of Treace Medical Concepts Inc?

To assess the risk management score of Treace Medical Concepts Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of Treace Medical Concepts Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Treace Medical Concepts Inc.